Author: digi

Consent and Assent Procedures in Vulnerable Groups

June 21, 2025

Consent and Assent Procedures in Vulnerable Groups Ethical Consent and Assent Procedures for Vulnerable Groups in Clinical Trials When involving vulnerable populations in clinical trials—such as children, mentally impaired individuals, prisoners, or institutionalized persons—standard informed consent practices require modification. Ethical guidelines and regulatory frameworks mandate special provisions, including assent, legally authorized representatives (LARs), and continuous…

Ethical Considerations in Vulnerable Populations, Informed Consent and Ethics Committees

CRF Design Principles for Accurate Data Capture in Clinical Trials

June 21, 2025

digi

CRF Design Principles to Ensure Accurate Clinical Trial Data Capture Case Report Forms (CRFs) are the backbone of clinical data collection. Whether paper-based or electronic (eCRFs), these tools must be designed with accuracy, compliance, and usability in mind. Poorly designed CRFs can lead to data inconsistencies, protocol deviations, and even regulatory rejection. This tutorial provides…

Clinical Research Operations, Data Collection and Management

Interpreting Safety and Efficacy Without Blinding – Clinical Trial Design and Protocol Development

June 21, 2025

digi

Interpreting Safety and Efficacy Without Blinding – Clinical Trial Design and Protocol Development “Understanding the Safety and Effectiveness in Unblinded Trials” Introduction Interpreting safety and efficacy without blinding in clinical studies is a challenging task that requires a comprehensive understanding of various factors governing the trial. It involves analysing raw data without the protective cover…

Clinical Trial Design and Protocol Development, Open-Label Studies

Common Findings in RMVs and How to Resolve Them Effectively

June 21, 2025

digi

How to Address Common Findings During Routine Monitoring Visits (RMVs) Routine Monitoring Visits (RMVs) play a critical role in ensuring the integrity and compliance of ongoing clinical trials. Conducted by Clinical Research Associates (CRAs), these visits often reveal recurring issues related to protocol adherence, documentation, and GCP compliance. This tutorial explores the most common RMV…

Routine Monitoring Visits, Site Management and Monitoring

Cultural Competency in Clinical Research Staff for Inclusive Trials

June 21, 2025

digi

Cultural Competency in Clinical Research Staff for Inclusive Trials How Cultural Competency in Clinical Research Staff Enhances Inclusive Clinical Trials As clinical trials aim for broader representation, the role of cultural competency among research staff becomes increasingly vital. Engaging diverse populations—especially those historically underrepresented in clinical studies—requires more than just translated documents or inclusive recruitment…

Diversity and Inclusion in Trials, Patient Recruitment and Retention

How to Compile Safety Data for PSUR Submission

June 21, 2025

digi

How to Compile Safety Data for PSUR Submission A Step-by-Step Guide to Compiling Safety Data for PSUR Submission The Periodic Safety Update Report (PSUR) is a critical pharmacovigilance document that requires comprehensive and well-organized safety data. Whether you’re compiling information from ongoing clinical trials or post-marketing surveillance, the success of your PSUR submission depends on…

Periodic Safety Update Reports (PSURs), Safety Reporting and Pharmacovigilance

Ethics of Open-Label Drug Access – Clinical Trial Design and Protocol Development

June 21, 2025

digi

Ethics of Open-Label Drug Access – Clinical Trial Design and Protocol Development “The Morality of Access to Unblinded Medication” Introduction The ethical implications of open-label drug access are complex and multifaceted. They traverse the fields of patient rights, scientific transparency, and the moral duty of pharmaceutical companies. Open-label drug access refers to the practice of…

Clinical Trial Design and Protocol Development, Open-Label Studies

Case Studies: Successful Enrollment Campaigns in Clinical Trials

June 21, 2025

digi

Case Studies of Successful Enrollment Campaigns in Clinical Trials Patient enrollment is one of the most critical and challenging components of clinical trial operations. While many trials struggle with delays due to slow recruitment, others have achieved remarkable success through innovative, data-driven strategies. In this tutorial, we explore real-world case studies that demonstrate how effective…

Clinical Research Operations, Patient Enrollment Strategies

Balancing CRF Data Collection Depth with Usability: Strategies for Optimized Design

June 21, 2025

digi

Balancing CRF Data Collection Depth with Usability: Strategies for Optimized Design Strategies for Balancing Data Depth and Usability in CRF Design Designing a Case Report Form (CRF) that collects all necessary clinical trial data without overwhelming site personnel is a delicate balancing act. Collect too little, and critical endpoints may be missed. Collect too much,…

Case Report Form (CRF) Design, Clinical Data Management

Ethical Dilemmas in Prisoner and Institutionalized Populations

June 21, 2025

digi

Ethical Dilemmas in Prisoner and Institutionalized Populations Addressing Ethical Dilemmas in Research Involving Prisoner and Institutionalized Populations Prisoners and individuals in mental health or other institutional facilities are considered highly vulnerable in clinical research. Due to their confinement, limited autonomy, and potential coercion, their participation in trials requires rigorous ethical scrutiny. This article explores the…

Ethical Considerations in Vulnerable Populations, Informed Consent and Ethics Committees